The global embolotherapy market achieved the size of USD 3.943 Bn in 2026.
Asia Pacific holds the largest share of the global embolotherapy market.
The primary factor projected to drive the embolotherapy market expansion is the rising demand for minimally invasive procedures propels the market, driven by faster recovery and safety.
In 2025, the embolic agents category held a significant share of the global market.
The hospitals and clinics segment constitutes a major share of the global embolotherapy market.